Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

Amyloidosis is a rare disease that involves the buildup of a specific protein called amyloid. Unlike other proteins, amyloid does not have a supportive role in the body. Instead, the buildup of ...

Transthyretin-mediated (ATTR) amyloidosis is a multisystem disease caused by the abnormal deposition of misfolded transthyretin protein as amyloid fibrils in various tissues. ATTR amyloidosis presents ...

Interviewer: Amyloidosis is a rare and possibly debilitating disease, which affects about 4,000 people a year in the United States. If left untreated, the disease can cause severe organ damage, so ...

In 2007, a group of American researchers discovered a new, very rare type of amyloidosis — one that targets a person’s kidneys. (1) Like other forms of amyloidosis, this newly discovered type involves ...

Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a buildup ...

The type of ATTR you have and how early it was diagnosed are two factors that can affect the prognosis of your disease.

Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is ...